SIA
MRK icon

SGL Investment Advisors’s Merck MRK Stock Holding History

SGL Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$884K Buy
7,946
+20
+0.3% +$2.31K 0.33% 65
2025
Q4 		$949K Sell
7,926
-664
-8% -$62.3K 0.38% 58
2025
Q3 		$709K Buy
8,590
+4,979
+138% +$410K 0.3% 71
2025
Q2 		$294K Sell
3,611
-168
-4% -$13.4K 0.14% 107
2025
Q1 		$293K Buy
3,779
+838
+28% +$78.2K 0.15% 96
2024
Q4 		$252K Buy
+2,941
New +$303K 0.13% 99

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SGL Investment Advisors's MRK Position: Q1 2026 in Review

SGL Investment Advisors increased its Merck (MRK) stake by 0.25% in Q1 2026, buying an estimated $2.31K and bringing the position to 7,946 shares worth $884K. The position accounts for 0.33% of the portfolio, ranked #65.

SGL Investment Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. The position peaked at $949K in Q4 2025. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SGL Investment Advisors held 7,946 shares of Merck worth $884K as of Q1 2026.
  • SGL Investment Advisors bought 20 Merck shares in Q1 2026, an estimated $2.31K.
  • Merck made up 0.33% of SGL Investment Advisors's portfolio in Q1 2026, its #65 holding.
  • SGL Investment Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • SGL Investment Advisors's Merck position peaked at $949K in Q4 2025.
  • 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.